# Role of Topical Vancomycin in Reducing Infections in Hip and Knee Arthroplasty

> **NCT05972603** · NA · UNKNOWN · sponsor: **Independent Public Healthcare Center in Rypin** · enrollment: 1000 (estimated)

## Conditions studied

- Osteoarthritis, Knee
- Osteoarthritis, Hip
- Rheumatoid Arthritis
- Avascular Necrosis of Hip

## Interventions

- **PROCEDURE:** 1.0 g Vancomycin powder into the wound
- **PROCEDURE:** 0,35% povidone-iodine solution lavage

## Key facts

- **NCT ID:** NCT05972603
- **Lead sponsor:** Independent Public Healthcare Center in Rypin
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2022-07-01
- **Primary completion:** 2024-06
- **Final completion:** 2024-12
- **Target enrollment:** 1000 (ESTIMATED)
- **Last updated:** 2023-08-02


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05972603

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05972603, "Role of Topical Vancomycin in Reducing Infections in Hip and Knee Arthroplasty". Retrieved via AI Analytics 2026-06-05 from https://api.ai-analytics.org/clinical/NCT05972603. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*